Trials / Unknown
UnknownNCT03306251
National Cohort of Children Born to HIV-positive Mothers
ANRS CO11 : National Cohort of Children Born to HIV-positive Mothers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,200 (estimated)
- Sponsor
- ANRS, Emerging Infectious Diseases · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.
Detailed description
The goal of the CO11 national cohort is to provide with CO1 a wider surveillance system to monitor changes in the rate of mother to child transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs. The CO11 EPF enrolle HIV infected women who delivery in maternity generally smaller than CO1 maternity (15 sites in Paris area, 35 in mainland France and 4 in the DOM). Maternal clinical, biological and therapeutic data before and during pregnancy were collected at delivery, with simplified questionnaires. The children are examined clinically and biologically at birth, 6, 12 and 24 months.
Conditions
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2017-10-11
- Last updated
- 2021-04-30
Locations
52 sites across 4 countries: France, French Guiana, Guadeloupe, Martinique
Source: ClinicalTrials.gov record NCT03306251. Inclusion in this directory is not an endorsement.